Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: A systematic review and cost-effectiveness analysis
- Submitting institution
-
University of Exeter
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 335
- Type
- D - Journal article
- DOI
-
10.3310/hta22490
- Title of journal
- Health Technology Assessment
- Article number
- -
- First page
- 1
- Volume
- 22
- Issue
- 49
- ISSN
- 1366-5278
- Open access status
- Compliant
- Month of publication
- September
- Year of publication
- 2018
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
13
- Research group(s)
-
C - Health Service Research
- Citation count
- 11
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
